We have constructed a panel of hyperstable immunoglobulin VL domains by a rational approach of consensus sequence engineering and combining stabilizing point mutations. These prototype domains unfold fully reversibly, even when the conserved structural disulfide bridge is reduced. This has allowed us to probe the factors that limit the expression yield of soluble immunoglobulin domains in the reducing environment of the cytoplasm (intrabodies). The most important factor is thermodynamic stability, and there is an excellent quantitative correlation between stability and yield. Surprisingly, an unprocessed N-terminal methionine residue can severely compromise VL stability, but this problem can be overcome by changing the amino acid following the initiator methionine residue. Transcription from the strong T7 promoter does not increase the amount of soluble material over that obtained from the tetA promoter, but large amounts of inclusions bodies can be obtained. Elevated temperature shifts protein from a productive folding pathway to aggregation. The structural disulfide bridge does not form in the cytoplasm, but the two consensus cysteine residues can be quantitatively oxidized in vitro. In summary, stability engineering provides a plannable route to the high-yield cytoplasmic expression of functional intrabody domains. Study holds ProTherm entries: 6068, 6069, 6070, 6071, 6072, 6073, 6074, 6075, 6076 Extra Details: additive : EDTA(20 mM),oxidized intrabodies; recombinant expression; VL domain;,protein stability; protein engineering
ID: vkjsHhys3
Submitter: Connie Wang
Submission Date: April 24, 2018, 8:31 p.m.
Version: 1
Number of data points | 9 |
Proteins | Ig gamma-1 chain C region secreted form ; IGA-KAPPA MCPC603 FV (LIGHT CHAIN) |
Unique complexes | 1 |
Assays/Quantities/Protocols | Experimental Assay: dG |
Libraries | Mutations for sequence DIVMTQSPSSLSVSAGERVTMSCKSSQSLLNSGNQKNFLAWYQQKPGQPPKLLIYGASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDHSYPLTFGAGTKLELKR |
Colors: | D | E | R | H | K | S | T | N | Q | A | V | I | L | M | F | Y | W | C | G | P |
---|